e-learning
resources
Virtual 2021
06.09.2021
Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Development of a self-management package for pulmonary fibrosis: an international Delphi study
J. Lee (Melbourne, Australia), G. Tikellis (Melbourne, Australia), A. Holland (Melbourne, Australia)
Source:
Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Session:
Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Session type:
E-poster
Number:
2381
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Lee (Melbourne, Australia), G. Tikellis (Melbourne, Australia), A. Holland (Melbourne, Australia). Late Breaking Abstract - Development of a self-management package for pulmonary fibrosis: an international Delphi study. 2381
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Late Breaking Abstract - COPD patient´s adherence to pulmonary rehabilitation programs: scoping review
Source: Virtual Congress 2021 – Pulmonary rehabilitation in asthma and COPD
Year: 2021
Late Breaking Abstract - Defining a severe asthma super-responder: findings from a Delphi process
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
Late Breaking Abstract - Idiopathic Pulmonary Fibrosis – a worldwide review of ‘real’ life’ practice: experience from a treatment feasibility review in 41 countries
Source: International Congress 2018 – ILDs: From bench to bedside
Year: 2018
Late Breaking Abstract - Use of a simple telecoaching pulmonary rehabilitation protocol for COPD patients.
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019
Late Breaking Abstract - Automated coaching for physical activity in COPD patients: results from a pilot study
Source: International Congress 2017 – Innovation in pulmonary rehabilitation and chronic care
Year: 2017
Late Breaking Abstract - Pharmacological and clinical management of severe asthma in 9 countries: An international survey of clinicians.
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
Late Breaking Abstract - Functional benefits of post COVID-19 multidisciplinary pulmonary rehabilitation program
Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases
Year: 2021
Late Breaking Abstract - Self-management interventions for patients with COPD – a Cochrane review
Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases
Year: 2021
Late Breaking Abstract - Exercise rehabilitation in telemedicine for COVID-19 patients.
Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation
Year: 2020
Late Breaking Abstract - The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey.
Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings
Year: 2019
Late Breaking Abstract - Home ventilators failure : a nation-wide cohort analysis.
Source: International Congress 2018 – Non-invasive ventilation for acute respiratory failure
Year: 2018
Late Breaking Abstract - Covid-19 management in an Italian Prison. Monitoring of pulmonary function using oscillometry.
Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases
Year: 2021
Quality of resistance training description in COPD trials: Study protocol for a systematic review
Source: International Congress 2016 – Latest insights into functional capacity and muscle weakness in chronic lung diseases
Year: 2016
Family integration in pulmonary rehabilitation programmes: A pilot study
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 1)
Year: 2013
Implementation of personalized treatment of asthma by improved phenotyping: Critical review of knowledge gaps and unmet research needs by the European asthma research & innovation partnership (EARIP) expert panel
Source: International Congress 2016 – Phenotyping asthma
Year: 2016
SPACE for COPD: Experiences of using a web based rehabilitation programme
Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases
Year: 2015
A qualitative study of patients' experiences of participating in SPACE for COPD: a Self-management Programme of Activity, Coping and Education
Source: ERJ Open Res, 3 (4) 00017-2017; 10.1183/23120541.00017-2017
Year: 2017
Late Breaking Abstract - Development of an animal model for group 3 Pulmonary Hypertension
Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Year: 2018
Late Breaking Abstract - Validation of a tool for the assessment of disease awareness (DA) in COPD
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
Late Breaking Abstract - RECEIVER trial: sustained use and improved outcomes with digitally supported COPD co-management
Source: Virtual Congress 2021 – E-health for COVID-19
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept